(Reuters) - The vaccine arm of Sanofi-Aventis is the only U.S.-based
producer of injectable flu vaccine. The plant will produce 150
million doses a year after the new 140,000-square-foot facility comes on line by 2010.
The $150 million facility will also be capable of producing
vaccine against pandemic strains of flu. Experts expect a
pandemic of influenza of some sort and the No. 1 suspect is the
H5N1 avian flu virus, which has so far infected 318 people and
killed 192 of them.
Read more at Reuters.com Government Filings News
producer of injectable flu vaccine. The plant will produce 150
million doses a year after the new 140,000-square-foot facility comes on line by 2010.
The $150 million facility will also be capable of producing
vaccine against pandemic strains of flu. Experts expect a
pandemic of influenza of some sort and the No. 1 suspect is the
H5N1 avian flu virus, which has so far infected 318 people and
killed 192 of them.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment